Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapy

Objectives In this post-hoc analysis of ESTHER trial, we aimed to investigate the longitudinal relationship between inflammation on MRI and the achievement of inactive disease/low disease activity in patients with axial spondyloarthritis (axSpA) treated with long-term tumor necrosis factor (TNF) inh...

Full description

Saved in:
Bibliographic Details
Main Authors: Joachim Sieper, Denis Poddubnyy, Fabian Proft, Mikhail Protopopov, Valeria Rios Rodriguez, Murat Torgutalp, Judith Rademacher, H Haibel, Kay-Geert Hermann, Christian Althoff
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/11/1/e004921.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556914517835776
author Joachim Sieper
Denis Poddubnyy
Fabian Proft
Mikhail Protopopov
Valeria Rios Rodriguez
Murat Torgutalp
Judith Rademacher
H Haibel
Kay-Geert Hermann
Christian Althoff
author_facet Joachim Sieper
Denis Poddubnyy
Fabian Proft
Mikhail Protopopov
Valeria Rios Rodriguez
Murat Torgutalp
Judith Rademacher
H Haibel
Kay-Geert Hermann
Christian Althoff
author_sort Joachim Sieper
collection DOAJ
description Objectives In this post-hoc analysis of ESTHER trial, we aimed to investigate the longitudinal relationship between inflammation on MRI and the achievement of inactive disease/low disease activity in patients with axial spondyloarthritis (axSpA) treated with long-term tumor necrosis factor (TNF) inhibitor etanercept.Methods Of the 76 patients with active axSpA in the ESTHER trial, we included all patients treated with etanercept for at least 6 months for main analysis. All clinical and MRI data from 4.5 years of follow-up were used in the analysis. MRIs of the spine and sacroiliac (SI) joints were performed at baseline, week 24, week 48 and yearly thereafter and were evaluated for active inflammatory lesions according to the Berlin MRI score.Results Longitudinal analysis showed that higher SI joint osteitis score was associated with higher Axial Spondyloarthritis Disease Activity Score (ASDAS) at the same time point (β=0.08, 95% CI (0.05; 0.11)) and at the next time point 6 months later (β=0.05, 95% CI (0.02; 0.07)). Furthermore, resolution of osteitis in the SI joint (Berlin MRI osteitis score of ≤1) was associated with lower ASDAS at the next time point (β=−0.26, 95% CI (−0.42; −0.09)), higher odds of achieving ASDAS low disease activity (OR=5.61, 95% CI (1.06; 29.67)) and inactive disease status (OR=2.23, 95% CI (1.01; 4.94)) at the next time point.Conclusions The presence of inflammation on SI joints-MRI is associated with higher disease activity in axSpA. Resolution of inflammation on MRI is associated with better clinical outcomes in the long-term follow-up. Thus, achieving complete resolution of inflammation is favourable for meeting the treatment goals in axSpA.Trial registration number NCT00844142.
format Article
id doaj-art-0cba86c209df4517a22aefdf3c193ec2
institution Kabale University
issn 2056-5933
language English
publishDate 2025-01-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj-art-0cba86c209df4517a22aefdf3c193ec22025-01-07T04:25:09ZengBMJ Publishing GroupRMD Open2056-59332025-01-0111110.1136/rmdopen-2024-004921Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapyJoachim Sieper0Denis Poddubnyy1Fabian Proft2Mikhail Protopopov3Valeria Rios Rodriguez4Murat Torgutalp5Judith Rademacher6H Haibel7Kay-Geert Hermann8Christian Althoff9Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gastroenterology, Infectious Diseases and Rheumatology (including Nutrition Medicine), Charite Universitatsmedizin Berlin, Berlin, GermanyCorporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gastroenterology, Infectious Diseases and Rheumatology (including Nutrition Medicine), Charite Universitatsmedizin Berlin, Berlin, GermanyCorporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gastroenterology, Infectious Diseases and Rheumatology (including Nutrition Medicine), Charite Universitatsmedizin Berlin, Berlin, GermanyCorporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gastroenterology, Infectious Diseases and Rheumatology (including Nutrition Medicine), Charite Universitatsmedizin Berlin, Berlin, GermanyCorporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gastroenterology, Infectious Diseases and Rheumatology (including Nutrition Medicine), Charite Universitatsmedizin Berlin, Berlin, GermanyCorporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gastroenterology, Infectious Diseases and Rheumatology (including Nutrition Medicine), Charite Universitatsmedizin Berlin, Berlin, GermanyCorporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gastroenterology, Infectious Diseases and Rheumatology (including Nutrition Medicine), Charite Universitatsmedizin Berlin, Berlin, GermanyCorporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gastroenterology, Infectious Diseases and Rheumatology (including Nutrition Medicine), Charite Universitatsmedizin Berlin, Berlin, GermanyCorporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiology (including Pediatric Radiology), Charité Universitätsmedizin Berlin, Berlin, GermanyHELIOS Klinikum Emil von Behring GmbH, Berlin, GermanyObjectives In this post-hoc analysis of ESTHER trial, we aimed to investigate the longitudinal relationship between inflammation on MRI and the achievement of inactive disease/low disease activity in patients with axial spondyloarthritis (axSpA) treated with long-term tumor necrosis factor (TNF) inhibitor etanercept.Methods Of the 76 patients with active axSpA in the ESTHER trial, we included all patients treated with etanercept for at least 6 months for main analysis. All clinical and MRI data from 4.5 years of follow-up were used in the analysis. MRIs of the spine and sacroiliac (SI) joints were performed at baseline, week 24, week 48 and yearly thereafter and were evaluated for active inflammatory lesions according to the Berlin MRI score.Results Longitudinal analysis showed that higher SI joint osteitis score was associated with higher Axial Spondyloarthritis Disease Activity Score (ASDAS) at the same time point (β=0.08, 95% CI (0.05; 0.11)) and at the next time point 6 months later (β=0.05, 95% CI (0.02; 0.07)). Furthermore, resolution of osteitis in the SI joint (Berlin MRI osteitis score of ≤1) was associated with lower ASDAS at the next time point (β=−0.26, 95% CI (−0.42; −0.09)), higher odds of achieving ASDAS low disease activity (OR=5.61, 95% CI (1.06; 29.67)) and inactive disease status (OR=2.23, 95% CI (1.01; 4.94)) at the next time point.Conclusions The presence of inflammation on SI joints-MRI is associated with higher disease activity in axSpA. Resolution of inflammation on MRI is associated with better clinical outcomes in the long-term follow-up. Thus, achieving complete resolution of inflammation is favourable for meeting the treatment goals in axSpA.Trial registration number NCT00844142.https://rmdopen.bmj.com/content/11/1/e004921.full
spellingShingle Joachim Sieper
Denis Poddubnyy
Fabian Proft
Mikhail Protopopov
Valeria Rios Rodriguez
Murat Torgutalp
Judith Rademacher
H Haibel
Kay-Geert Hermann
Christian Althoff
Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapy
RMD Open
title Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapy
title_full Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapy
title_fullStr Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapy
title_full_unstemmed Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapy
title_short Association between resolution of MRI-detected inflammation and improved clinical outcomes in axial spondyloarthritis under long-term anti-TNF therapy
title_sort association between resolution of mri detected inflammation and improved clinical outcomes in axial spondyloarthritis under long term anti tnf therapy
url https://rmdopen.bmj.com/content/11/1/e004921.full
work_keys_str_mv AT joachimsieper associationbetweenresolutionofmridetectedinflammationandimprovedclinicaloutcomesinaxialspondyloarthritisunderlongtermantitnftherapy
AT denispoddubnyy associationbetweenresolutionofmridetectedinflammationandimprovedclinicaloutcomesinaxialspondyloarthritisunderlongtermantitnftherapy
AT fabianproft associationbetweenresolutionofmridetectedinflammationandimprovedclinicaloutcomesinaxialspondyloarthritisunderlongtermantitnftherapy
AT mikhailprotopopov associationbetweenresolutionofmridetectedinflammationandimprovedclinicaloutcomesinaxialspondyloarthritisunderlongtermantitnftherapy
AT valeriariosrodriguez associationbetweenresolutionofmridetectedinflammationandimprovedclinicaloutcomesinaxialspondyloarthritisunderlongtermantitnftherapy
AT murattorgutalp associationbetweenresolutionofmridetectedinflammationandimprovedclinicaloutcomesinaxialspondyloarthritisunderlongtermantitnftherapy
AT judithrademacher associationbetweenresolutionofmridetectedinflammationandimprovedclinicaloutcomesinaxialspondyloarthritisunderlongtermantitnftherapy
AT hhaibel associationbetweenresolutionofmridetectedinflammationandimprovedclinicaloutcomesinaxialspondyloarthritisunderlongtermantitnftherapy
AT kaygeerthermann associationbetweenresolutionofmridetectedinflammationandimprovedclinicaloutcomesinaxialspondyloarthritisunderlongtermantitnftherapy
AT christianalthoff associationbetweenresolutionofmridetectedinflammationandimprovedclinicaloutcomesinaxialspondyloarthritisunderlongtermantitnftherapy